{"created":"2023-05-15T14:46:05.657000+00:00","id":62965,"links":{},"metadata":{"_buckets":{"deposit":"a0e2bf44-506a-470a-830f-9abf5f957530"},"_deposit":{"created_by":1,"id":"62965","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"62965"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00062965","sets":["10:29"]},"author_link":["621956","621960","621955","621957","621961","621966","621958","621959","621963","621965","621962","621964"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2008-04-15","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The purpose of this study is to clarify how the combination of temozolomide (temodar) and carbon particle therapy suppress tumor growth for glioblastomas. We used human glioblastoma cells and BALS/c-mu/nu mice for in vivo experiment. Grouwth suppression was significantly potentiated by combined treatment with carbon particle and temozolomide as compared to that treated with either of them alone.","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"H19年度HIMAC共同利用研究成果発表会","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"吉田, 由香里"}],"nameIdentifiers":[{"nameIdentifier":"621955","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"加藤, 弘之"}],"nameIdentifiers":[{"nameIdentifier":"621956","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鈴木, 義行"}],"nameIdentifiers":[{"nameIdentifier":"621957","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石内, 勝吾"}],"nameIdentifiers":[{"nameIdentifier":"621958","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"加藤, 真吾"}],"nameIdentifiers":[{"nameIdentifier":"621959","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"中野, 隆史"}],"nameIdentifiers":[{"nameIdentifier":"621960","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉田 由香里","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"621961","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"加藤 弘之","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"621962","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鈴木 義行","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"621963","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石内 勝吾","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"621964","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"加藤 眞吾","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"621965","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"中野 隆史","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"621966","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"重粒子線と化学療法の併用療法における脳正常組織および神経膠芽腫の放射線感受性の検討","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"重粒子線と化学療法の併用療法における脳正常組織および神経膠芽腫の放射線感受性の検討"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2009-02-04"},"publish_date":"2009-02-04","publish_status":"0","recid":"62965","relation_version_is_last":true,"title":["重粒子線と化学療法の併用療法における脳正常組織および神経膠芽腫の放射線感受性の検討"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:24:43.426925+00:00"}